LTBK-12. EORTC 26951, RANDOMIZED STUDY OF ADJUVANT PCV AFTER 59.4 GY RADIOTHERAPY: VERY LONG TERM FOLLOW-UP

BACKGROUND: Between 1995 and 2002 the EORTC Brain Tumor Group conducted a prospective phase III study on adjuvant procarbazine, CCNU and vincristine (PCV) chemotherapy in anaplastic oligodendroglioma (AOD). A mature follow-up presented in 2012 showed survival benefit of the addition of PCV, in parti...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: van den Bent, Martin, Hoang-Xuan, Khe, Brandes, Alba, Kros, Johan, Kouwenhoven, M C M, Taphoorn, Martin, Delattre, Jean-Yves, Bernsen, Hans, Frenay, Marc, Synhaeve, Nathalie, Weller, Michael, Enting, Roelien, French, Pim, Dinjens, Winand, Golfinopoulos, Vassilis, Gorlia, Thierry
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Late Breaking Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6873623/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz219.1201
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky